DocuSign Stock Forecast, Price & News

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DocuSign in the last twelve months. There are currently 3 hold ratings and 16 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DocuSign stock.
View analyst ratings for DocuSign or view top-rated stocks.

Wall Street analysts have given DocuSign a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DocuSign wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

DocuSign is scheduled to release its next quarterly earnings announcement on Thursday, December 2nd 2021.
View our earnings forecast for DocuSign.

DocuSign, Inc. (NASDAQ:DOCU) issued its quarterly earnings results on Wednesday, September, 1st. The company reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.07. The firm had revenue of $511.84 million for the quarter, compared to the consensus estimate of $487.99 million. DocuSign had a negative net margin of 9.18% and a negative trailing twelve-month return on equity of 23.08%. DocuSign's revenue for the quarter was up 49.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.17 earnings per share.
View DocuSign's earnings history.

DocuSign's stock was trading at $75.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DOCU stock has increased by 261.7% and is now trading at $271.29.
View which stocks have been most impacted by COVID-19.

DocuSign issued an update on its FY 2022 earnings guidance on Thursday, September, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.08 billion-$2.09 billion, compared to the consensus revenue estimate of $2.05 billion.

19 brokerages have issued 1 year price targets for DocuSign's stock. Their forecasts range from $215.00 to $389.00. On average, they expect DocuSign's stock price to reach $314.78 in the next year. This suggests a possible upside of 16.0% from the stock's current price.
View analysts' price targets for DocuSign or view top-rated stocks among Wall Street analysts.

782 employees have rated DocuSign CEO Daniel Springer on Glassdoor.com. Daniel Springer has an approval rating of 98% among DocuSign's employees. This puts Daniel Springer in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to DocuSign include Shopify (SHOP), SAP (SAP), Intuit (INTU), ServiceNow (NOW), Square (SQ), Snowflake (SNOW), Dassault Systèmes (DASTY), Autodesk (ADSK), Twilio (TWLO), Activision Blizzard (ATVI), CrowdStrike (CRWD), VMware (VMW), Atlassian (TEAM), NetEase (NTES) and Palantir Technologies (PLTR).
View all of DOCU's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other DocuSign investors own include NVIDIA (NVDA), Square (SQ), Tesla (TSLA), Advanced Micro Devices (AMD), Zoom Video Communications (ZM), PayPal (PYPL), salesforce.com (CRM), Alibaba Group (BABA), Shopify (SHOP) and Netflix (NFLX).

(DOCU) raised $542 million in an initial public offering (IPO) on Friday, April 27th 2018. The company issued 21,700,000 shares at a price of $24.00-$26.00 per share. Morgan Stanley and J.P. Morgan served as the underwriters for the IPO and Citigroup, BofA Merrill Lynch, Deutsche Bank Securities, JMP Securities, Pper Jaffray and William Blair were co-managers.

DocuSign trades on the NASDAQ under the ticker symbol "DOCU."

DocuSign's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.70%), BlackRock Inc. (5.77%), Price T Rowe Associates Inc. MD (5.63%), Morgan Stanley (3.42%), Jennison Associates LLC (2.63%) and State Street Corp (2.10%). Company insiders that own DocuSign stock include Daniel D Springer, Enrique T Salem, Enrique T Salem, John M Hinshaw, Kirsten O Wolberg, Loren Alhadeff, Peter Solvik and Scott V Olrich.
View institutional ownership trends for DocuSign.

DOCU stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, FMR LLC, BlackRock Inc., Bain Capital Venture Investors LLC, PEAK6 Investments LLC, ARK Investment Management LLC, Renaissance Technologies LLC, and Susquehanna International Group LLP. Company insiders that have sold DocuSign company stock in the last year include Daniel D Springer, Enrique T Salem, Loren Alhadeff, Peter Solvik, and Scott V Olrich.
View insider buying and selling activity for DocuSign or view top insider-selling stocks.

DOCU stock was acquired by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Price T Rowe Associates Inc. MD, Morgan Stanley, Macquarie Group Ltd., Clearbridge Investments LLC, Vanguard Group Inc., State Street Corp, and 1832 Asset Management L.P..
View insider buying and selling activity for DocuSign or or view top insider-buying stocks.

Shares of DOCU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DOCU stock can currently be purchased for approximately $271.29.

DocuSign has a market capitalization of $53.37 billion and generates $1.45 billion in revenue each year. The company earns $-243,270,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.

DocuSign employs 5,630 workers across the globe.

The official website for DocuSign is www.docusign.com.

DocuSign is headquartered at 221 Main St. Suite 1550, San Francisco CA, 94105.

DocuSign's mailing address is 221 Main St. Suite 1550, San Francisco CA, 94105. The company can be reached via phone at (415) 489-4940 or via email at [email protected].